Prevalence, Needs, Strategies, and Risk Factors for Neurodegenerative Diseases. Activation of Microglia and Macrophages in Neurodegenerative Diseases.- Activation of Astrocytes in Neurodegenerative Diseases.- Tau Pathology in Neurodegenerative Diseases.- Role of SIRT3 and Mitochondrial Dysfunction in Neurodegeneration.- Oxidative Stress and Cellular Dysfunction in Neurodegeneratiove Disease.- Biomarkers in Parkinson’s Disease.- Metabolomic Biomarkers in Parkinson’s Disease.- Neuroinflammation in Huntington’s Disease.- Biomarkers in Huntington Disease.- Biofluid Biomarkers of Amyotrophic Lateral Sclerosis.- MicroRNAs in Blood Serum, Blood Plasma, and Cerebrospinal Fluid as Diagnostic Biomarkers of Alzheimer’s Disease.- Tau Biomarkers for Long-Term Effects of Neurotrauma: Technology Versus the Null Hypothesis.- Impedimetric Immunosensing for Neuroinflammatory Biomarker Profiling.- Aptamers Detection of Neurodegenerative Disease Biomarkers.- Possible Biomarkers for Frontotemporal Dementia and to Differentiate from Alzheimer’s Disease and Amyotrophic Lateral Sclerosis.- TSPO PET Imaging as a Biomarker of Neuroinflammation in Neurodegenerative Disorders.- Validation of Diffusion Kurtosis Imaging as an Early Stage Biomarker of Parkinson’s Disease in Animal Models.- Imaging Biomarkers in Huntington’s Disease.- Imaging Biomarkers in Amyotrophic Lateral Sclerosis.- Trends in Biomarkers of Neurodegenerative Diseases.
